• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃分化腺癌中5号染色体长臂上两个不同的缺失区域。

Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.

作者信息

Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, Terashima M, Saito K, Satodate R

机构信息

Department of Pathology, Iwate Medical University School of Medicine, Japan.

出版信息

Cancer Res. 1996 Feb 1;56(3):612-5.

PMID:8564980
Abstract

Frequent loss of heterozygosity (LOH) on the long arm of chromosome 5 (5q) has been reported in many types of human malignancies, including gastric carcinoma. One of the targets of 5q-LOH in colorectal carcinoma is certainly the adenomatous polyposis coli (APC) gene on 5q21. However, other evidence has suggested the presence of another tumor suppressor gene in this region which may be inactivated in gastric carcinoma. In the present study, to determine the location of the putative tumor suppressor gene on 5q, LOH at nine microsatellite loci on 5q were investigated at 38 differentiated adenocarcinomas of the stomach that probably did not carry APC mutations. LOH at any locus on 5q occurred in 37% (14 of 38) of the tumors. Although many tumors exhibited large interstitial deletions on 5q that included the APC locus (5q21), we have identified minimum regions of deletion as the D5S428 locus and the interferon regulatory factor-1 (IRF-1) locus. Thus, at least two putative tumor suppressor genes, which play a crucial role in the genesis of differentiated adenocarcinoma of the stomach and are distinct from the APC gene, lie on 5q.

摘要

在包括胃癌在内的多种人类恶性肿瘤中,均有关于5号染色体长臂(5q)杂合性缺失(LOH)频发的报道。在结直肠癌中,5q-LOH的靶点之一无疑是位于5q21的腺瘤性息肉病 coli(APC)基因。然而,其他证据表明该区域存在另一种肿瘤抑制基因,其在胃癌中可能失活。在本研究中,为确定5q上假定的肿瘤抑制基因的位置,对38例可能未携带APC突变的胃分化腺癌中5q上的9个微卫星位点的LOH进行了研究。5q上任何位点的LOH发生在37%(38例中的14例)的肿瘤中。尽管许多肿瘤在5q上表现出包括APC位点(5q21)在内的大片段间质性缺失,但我们已将最小缺失区域确定为D5S428位点和干扰素调节因子-1(IRF-1)位点。因此,至少有两个假定的肿瘤抑制基因位于5q上,它们在胃分化腺癌的发生中起关键作用,且与APC基因不同。

相似文献

1
Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.胃分化腺癌中5号染色体长臂上两个不同的缺失区域。
Cancer Res. 1996 Feb 1;56(3):612-5.
2
Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach.胃腺瘤和分化型腺癌中的微卫星改变
Cancer Res. 1995 May 1;55(9):1933-6.
3
Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach.胃分化腺癌中21号染色体长臂上的常见缺失区域。
Genes Chromosomes Cancer. 1997 Apr;18(4):318-21.
4
Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.胃腺癌中11号染色体杂合性缺失
Cancer Res. 1996 Jan 15;56(2):268-72.
5
Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.人类胃癌中1号染色体长臂、5号染色体长臂和17号染色体短臂上杂合性的频繁缺失。
Cancer Res. 1991 Jun 1;51(11):2926-31.
6
Characterization of the APC gene in sporadic gastric adenocarcinomas.散发性胃腺癌中APC基因的特征分析。
Oncogene. 1996 May 2;12(9):1953-9.
7
Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22.散发性卵巢癌中5号染色体杂合性缺失是一个晚期事件,且与5q21 - 22处的腺瘤性息肉病基因(APC)突变无关。
Hum Mutat. 1994;3(3):283-91. doi: 10.1002/humu.1380030317.
8
Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.胃癌癌前病变及腺癌中的微卫星不稳定性
Cancer. 1996 Apr 15;77(8 Suppl):1620-7. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1620::AID-CNCR30>3.0.CO;2-#.
9
Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma.11p15区域的等位基因缺失在食管腺癌和胃腺癌中很常见。
Cancer. 1998 Jul 15;83(2):232-9.
10
[Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].[原发性胃癌7号染色体长臂31区最小常见缺失区域及其临床意义]
Ai Zheng. 2005 Nov;24(11):1306-11.

引用本文的文献

1
The RNA mA reader IGF2BP3 regulates NFAT1/IRF1 axis-mediated anti-tumor activity in gastric cancer.RNA mA 阅读器 IGF2BP3 调节胃癌中 NFAT1/IRF1 轴介导的抗肿瘤活性。
Cell Death Dis. 2024 Mar 6;15(3):192. doi: 10.1038/s41419-024-06566-0.
2
Human inborn errors of immunity associated with IRF4.与 IRF4 相关的人类先天性免疫缺陷
Front Immunol. 2023 Sep 22;14:1236889. doi: 10.3389/fimmu.2023.1236889. eCollection 2023.
3
CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling.
CSNK2B 调节 IRF1 与功能 DNA 元件的结合,促进基础和激动剂诱导的抗病毒信号转导。
Nucleic Acids Res. 2023 May 22;51(9):4451-4466. doi: 10.1093/nar/gkad298.
4
Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer.干扰素调节因子 1 通过调控 PANoptosis 防止结直肠癌。
JCI Insight. 2020 Jun 18;5(12):136720. doi: 10.1172/jci.insight.136720.
5
Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells.Wnt/β-catenin 信号通路下游抑制 IRF1 表达对结直肠癌细胞的抗凋亡作用。
Oncogene. 2019 Aug;38(32):6051-6064. doi: 10.1038/s41388-019-0856-9. Epub 2019 Jul 10.
6
Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells.番茄红素通过激活肺癌细胞的IFN信号通路提高抗PD-1治疗的效率。
Cancer Cell Int. 2019 Mar 21;19:68. doi: 10.1186/s12935-019-0789-y. eCollection 2019.
7
Novel IRF-1 Mutations in a Small Cohort of Leukaemia Patients From Saudi Arabia.沙特阿拉伯一小群白血病患者中的新型IRF-1突变
Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2795-2801. doi: 10.22034/APJCP.2017.18.10.2795.
8
Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instability.染色体不稳定型胃癌中netrin-1受体的遗传和表观遗传改变
Clin Epigenetics. 2015 Jul 23;7(1):73. doi: 10.1186/s13148-015-0096-y. eCollection 2015.
9
Identification of IRF1 as critical dual regulator of Smac mimetic-induced apoptosis and inflammatory cytokine response.鉴定 IRF1 为 Smac 模拟物诱导的细胞凋亡和炎症细胞因子反应的关键双重调节因子。
Cell Death Dis. 2014 Dec 11;5(12):e1562. doi: 10.1038/cddis.2014.498.
10
Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis.干扰素调节因子-1抑制肿瘤发生的功能及机制。
Oncol Lett. 2013 Feb;5(2):417-423. doi: 10.3892/ol.2012.1051. Epub 2012 Nov 28.